Verastem, Inc.

VSTM · Nasdaq · SIC 2834: Pharmaceutical Preparations
247
SEC Filings

Business Summary

Verastem, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing medicines for cancer. Its marketed product is AVMAPKI FAKZYNJA CO-PACK (avutometinib capsules; defactinib tablets). Its pipeline includes avutometinib (RAF/MEK inhibitor), defactinib (FAK inhibitor), and VS-7375 (a selective oral KRAS G12D dual ON/OFF inhibitor). The company conducts clinical trials including RAMP 201, RAMP 201J, RAMP 205, RAMP 301, and VS-7375 trials.

Next Earnings

Q2 FY2026 — expected 2026-09-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionVSTMdiscussed_in_filing Cybersecurity
topic_mentionVSTMdiscussed_in_filing Trusted Computing
topic_mentionVSTMdiscussed_in_filing Blockchain & Crypto
topic_mentionVSTMdiscussed_in_filing Regulation
topic_mentionVSTMdiscussed_in_filing Healthcare & Bio
topic_mentionVSTMdiscussed_in_filing Sovereign & Government
topic_mentionVSTMdiscussed_in_filing Cybersecurity
topic_mentionVSTMdiscussed_in_filing Trusted Computing
topic_mentionVSTMdiscussed_in_filing Blockchain & Crypto
topic_mentionVSTMdiscussed_in_filing Regulation
topic_mentionVSTMdiscussed_in_filing Healthcare & Bio
topic_mentionVSTMdiscussed_in_filing Sovereign & Government
topic_mentionVSTMdiscussed_in_filing Cybersecurity
topic_mentionVSTMdiscussed_in_filing Trusted Computing
topic_mentionVSTMdiscussed_in_filing Blockchain & Crypto
topic_mentionVSTMdiscussed_in_filing Regulation
topic_mentionVSTMdiscussed_in_filing Healthcare & Bio
topic_mentionVSTMdiscussed_in_filing Sovereign & Government
topic_mentionVSTMdiscussed_in_filing Cybersecurity
topic_mentionVSTMdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-042025-12-310001104659-26-023444EDGAR103K words
2025-03-202024-12-310001558370-25-003372EDGAR—
2024-03-142023-12-310001558370-24-003250EDGAR—
2023-03-142022-12-310001558370-23-003738EDGAR—
2022-03-282021-12-310001558370-22-004498EDGAR—
2021-03-182020-12-310001558370-21-003211EDGAR—
2020-03-112019-12-310001558370-20-002421EDGAR—
2019-03-122018-12-310001558370-19-001852EDGAR—
2018-03-132017-12-310001558370-18-001953EDGAR—
2017-03-232016-12-310001558370-17-002065EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001104659-25-106279EDGAR38K words
2025-08-072025-06-300001558370-25-010757EDGAR—
2025-05-132025-03-310001558370-25-007570EDGAR—
2024-11-062024-09-300001558370-24-014640EDGAR—
2024-08-082024-06-300001558370-24-011599EDGAR—
2024-05-092024-03-310001558370-24-007607EDGAR—
2023-11-082023-09-300001558370-23-018281EDGAR—
2023-08-082023-06-300001558370-23-013946EDGAR—
2023-05-092023-03-310001558370-23-008839EDGAR—
2022-11-032022-09-300001558370-22-016278EDGAR—
2022-08-082022-06-300001558370-22-012638EDGAR—
2022-05-092022-03-310001558370-22-007848EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-040001104659-26-023462EDGAR6K words
2026-02-040001104659-26-010036EDGAR—
2026-01-080001104659-26-002135EDGAR—
2025-12-310001104659-25-125309EDGAR—
2025-12-190001104659-25-123295EDGAR—
2025-11-170001104659-25-112946EDGAR—
2025-11-040001104659-25-105923EDGAR—
2025-10-230001104659-25-101817EDGAR—
2025-10-200001104659-25-100537EDGAR—
2025-09-080001104659-25-088021EDGAR—

247 total filings indexed. 215 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

oncology biopharmaceuticals clinical-stage-cancer-therapeutics

Company Identity

CIK0001526119
TickerVSTM
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedMA

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 71c1478ecf84c5f12c05fa19fb822453bae48147985be04d190781b045ef8cae
parent: a879c23b9e7031e56012d5b7d7b20c21393cf2cb4120e6592e122b863c3409f5
content hash: d25fa46b071d1d3935e562f56be9ea6ccbdb682483be00aac34d3a5c468da7bd
signed: 2026-04-13T04:48:09.083Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf